Minapharm Pharmaceuticals (CAI:MIPH) Inventory Turnover: 0.75 (As of Dec. 2025)

What is Minapharm Pharmaceuticals Inventory Turnover?

Minapharm Pharmaceuticals CAI:MIPH -0.27% 41 Inventory Turnover is 0.75 as of Dec. 2025. GuruFocus rates CAI:MIPH with a GF Score™ of 41/100 and a GF Value™ of E£362.31 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Minapharm Pharmaceuticals's Cost of Goods Sold for the three months ended in Dec. 2025 was E£1,054 Mil. Minapharm Pharmaceuticals's Average Total Inventories for the quarter that ended in Dec. 2025 was E£1,410 Mil. Minapharm Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2025 was 0.75.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Minapharm Pharmaceuticals's Days Inventory for the three months ended in Dec. 2025 was 122.06.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Minapharm Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.88.

Minapharm Pharmaceuticals (CAI:MIPH) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Minapharm Pharmaceuticals's Days Inventory for the three months ended in Dec. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2025 )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
	=	1409.622	/	1053.833	*	365 / 4
	=	122.06

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Minapharm Pharmaceuticals's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	1409.622	/	1598.112
	=	0.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Minapharm Pharmaceuticals Inventory Turnover Related Terms

Minapharm Pharmaceuticals Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Minapharm Pharmaceuticals's Inventory Turnover can be seen below:

Minapharm Pharmaceuticals Inventory Turnover Chart

Minapharm Pharmaceuticals Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

2.72

2.82

2.79

3.20

3.03

Minapharm Pharmaceuticals Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
Inventory Turnover	Get a 7-Day Free Trial															0.92	0.81	0.83	0.80	0.75

41GF Score

Minapharm Pharmaceuticals CAI:MIPH

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Minapharm Pharmaceuticals Inventory Turnover Calculation

Minapharm Pharmaceuticals's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	4132.372	/ (	(1232.578	+	1494.762)	/	2 )
=	4132.372	/	1363.67
=	3.03

Minapharm Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

	Inventory Turnover (Q: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Dec. 2025 )	/ (	(Total Inventories (Q: Sep. 2025 )	+	Total Inventories (Q: Dec. 2025 ))	/	count )
=	1053.833	/ (	(1324.482	+	1494.762)	/	2 )
=	1053.833	/	1409.622
=	0.75

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.75 mean?

Minapharm Pharmaceuticals (CAI:MIPH) has a Inventory Turnover of 0.75 as of Dec. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Minapharm Pharmaceuticals and its competitors.

Is Minapharm Pharmaceuticals' Inventory Turnover too high?

Minapharm Pharmaceuticals' current Inventory Turnover is 0.75. Overall, Minapharm Pharmaceuticals has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Minapharm Pharmaceuticals' Inventory Turnover compare to ZTS and UTHR?

Minapharm Pharmaceuticals' Inventory Turnover of 0.75 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Drug Manufacturers company?

A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Minapharm Pharmaceuticals and its competitors. Minapharm Pharmaceuticals's current Inventory Turnover is 0.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Minapharm Pharmaceuticals stock overvalued right now?

Based on GuruFocus' analysis, Minapharm Pharmaceuticals (CAI:MIPH) is currently considered Significantly Overvalued. The stock's GF Value™ is E£362.31, compared to a current price of E£698.08 — trading 92.7% above its estimated fair value. The current Inventory Turnover is 0.75. Minapharm Pharmaceuticals' overall GF Score™ is 41/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Minapharm Pharmaceuticals (CAI:MIPH), the current Inventory Turnover is 0.75 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Minapharm Pharmaceuticals (CAI:MIPH) Overvalued in 2026?

Based on GuruFocus' analysis, Minapharm Pharmaceuticals stock appears to be overvalued. The current stock price of E£698.08 is trading 92.7% above its estimated GF Value™ of E£362.31. GuruFocus considers Minapharm Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for CAI:MIPH:

Inventory Turnover: 0.75
GF Value™: E£362.31 vs. price of E£698.08 (92.7% above fair value)
GF Score™: 41/100 with 10 warning signs

No single metric tells the full story. See the CAI:MIPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Minapharm Pharmaceuticals Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies CAI:NIPH CAI:RMDA CAI:PHAR XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR HKSE:03692 VTRS NSE:DIVISLAB OSTO:SOBI NBIX NSE:TORNTPHARM SHSE:688506

Address El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY

Website https://www.minapharm.com

Minapharm Pharmaceuticals is a company whose purpose is to produce medicines and chemicals. medical supplies. cosmetics, veterinary medicines, dental supplies, and the production of dietary supplements and herbal medicines. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

41GF Score

Get the complete analysis for CAI:MIPH

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£698.08

Price

E£362.31

GF Value

View CAI:MIPH Analysis

See Inventory Turnover data for all stocks →